← Scroll for more →
4D Molecular Therapeutics, Inc. (FDMT)
Biological Products, (No Diagnostic Substances)
Latest Price
$14.31
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
5.80
P/B Ratio
2.47
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Jupiter Topco LLC | 5.75M | $76.0M | 10.41% | -- | 2026-06-30 |
| RA Capital Management, L.P. | 5.05M | $67.0M | 9.15% | -- | 2026-06-30 |
| BlackRock, Inc. | 4.55M | $60.0M | 8.23% | +400.8K | 2026-06-30 |
| Goldman Sachs Group Inc | 4.26M | $56.0M | 7.71% | +53.2K | 2026-06-30 |
| Novo Holdings A/S | 3.25M | $43.0M | 5.88% | -401.6K | 2026-06-30 |
| State Street Corp | 2.91M | $38.0M | 5.27% | +203.2K | 2026-06-30 |
| Bvf Inc | 2.88M | $38.0M | 5.21% | -- | 2026-06-30 |
| T. Rowe Price Investment Management, Inc. | 2.51M | $33.0M | 4.55% | -- | 2026-06-30 |
| Adage Capital Partners GP, L.L.C. | 2.25M | $29.0M | 4.07% | +644.0K | 2026-06-30 |
| Trails Edge Capital Partners, LP | 2.23M | $29.0M | 4.04% | +925.0K | 2026-06-30 |